Opportunity Information: Apply for RFA DA 21 040

The National Institutes of Health (NIH) published this discretionary grant funding opportunity, RFA-DA-21-040, titled "Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)." It uses the R01 research project grant mechanism and sits in the Education and Health funding activity category under CFDA 93.279. The core aim is to bring data and computational scientists into HIV and addiction research by encouraging proposals that use big data methods to better explain how HIV behaves biologically and how that biology intersects with substance use disorder (SUD). A key restriction is that clinical trials are not allowed under this announcement, meaning the work should focus on computational, analytical, and related research approaches rather than running intervention studies in humans.

The scientific emphasis is on creating and applying novel ways to integrate data that differ in both type and scale, with the idea that important signals are currently buried across disconnected datasets. The FOA is looking for projects that go beyond routine analyses and instead develop or substantially advance computational, bioinformatics, statistical, and other analytical approaches that can combine heterogeneous data sources in a meaningful way. In practice, that could involve integrating multi-omic data with clinical and behavioral data, linking longitudinal health records with molecular measurements, or developing methods that can reconcile population-level patterns with cellular or tissue-level mechanisms. The expectation is that these innovations in data integration and analysis will open up lines of inquiry that were previously out of reach and will uncover new insights into addiction biology in the context of HIV, including mechanistic pathways that may explain why outcomes differ across individuals or subgroups with different substance use profiles.

Because the FOA is framed around "big data science," it is essentially prioritizing methodological innovation and cross-cutting analytics over narrowly scoped, single-dataset studies. Successful projects would typically propose a clear plan for handling complex data challenges such as harmonizing variables across studies, addressing missingness and bias, scaling computation, improving reproducibility, and validating findings across independent datasets. The underlying theme is that the combination of sophisticated computational approaches with rich, multi-source data can clarify HIV activity and host response in ways that also reflect the real-world biological and behavioral complexities introduced by substance use disorder.

Eligibility is broad and intentionally inclusive. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments that are federally recognized; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other entities. The FOA also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible agencies of the federal government; regional organizations; U.S. territories or possessions; tribal governments other than federally recognized; and non-domestic (non-U.S.) entities, meaning foreign organizations can apply as well.

From an administrative standpoint, the opportunity was created on 2020-12-28 and originally closed on 2021-02-09. The listed award ceiling is $350,000, and the number of expected awards is not specified in the provided source data. Overall, the announcement is best understood as NIH signaling a strong interest in high-impact computational research that can fuse diverse data streams into coherent biological insight, specifically to illuminate the intertwined mechanisms of HIV and substance use disorder, without conducting clinical trials.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2020-12-28.
  • Applicants must submit their applications by 2021-02-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $350,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA DA 21 040

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Previous opportunity: NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 21 040

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 21 040) also looked into and applied for these:

Funding Opportunity
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed Apply for PAR 21 104

Funding Number: PAR 21 104
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) Apply for PAR 21 105

Funding Number: PAR 21 105
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional) Apply for RFA MH 21 145

Funding Number: RFA MH 21 145
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $2,000,000
HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) Apply for RFA DA 21 030

Funding Number: RFA DA 21 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,750,000
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) Apply for PA 21 110

Funding Number: PA 21 110
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) Apply for RFA DA 22 004

Funding Number: RFA DA 22 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) Apply for RFA DA 22 006

Funding Number: RFA DA 22 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $400,000
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 21 030

Funding Number: RFA CA 21 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) Apply for RFA DA 22 010

Funding Number: RFA DA 22 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Apply for PAR 21 190

Funding Number: PAR 21 190
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) Apply for PAR 21 318

Funding Number: PAR 21 318
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) Apply for PAR 21 111

Funding Number: PAR 21 111
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Apply for PAR 21 128

Funding Number: PAR 21 128
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Apply for PAR 21 061

Funding Number: PAR 21 061
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) Apply for PAR 21 183

Funding Number: PAR 21 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 21 036

Funding Number: RFA CA 21 036
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed) Apply for RFA LM 21 001

Funding Number: RFA LM 21 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 21 206

Funding Number: PAR 21 206
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,000
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Apply for PAR 21 166

Funding Number: PAR 21 166
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,000
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 21 208

Funding Number: PAR 21 208
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 21 040", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: